SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-013703
Filing Date
2022-04-06
Accepted
2022-04-06 16:32:06
Documents
13
Period of Report
2022-03-31
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K mtcr-8k_20220331.htm   iXBRL 8-K 36577
  Complete submission text file 0001564590-22-013703.txt   201203

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20220331.xsd EX-101.SCH 5945
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtcr-20220331_def.xml EX-101.DEF 13905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20220331_lab.xml EX-101.LAB 23880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20220331_pre.xml EX-101.PRE 14694
7 EXTRACTED XBRL INSTANCE DOCUMENT mtcr-8k_20220331_htm.xml XML 5287
Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 22810961
SIC: 2834 Pharmaceutical Preparations